These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 34650444)
21. Biological Significance of YAP/TAZ in Pancreatic Ductal Adenocarcinoma. Hayashi H; Uemura N; Zhao L; Matsumura K; Sato H; Shiraishi Y; Baba H Front Oncol; 2021; 11():700315. PubMed ID: 34395269 [TBL] [Abstract][Full Text] [Related]
22. Hepatocyte Stress Increases Expression of Yes-Associated Protein and Transcriptional Coactivator With PDZ-Binding Motif in Hepatocytes to Promote Parenchymal Inflammation and Fibrosis. Mooring M; Fowl BH; Lum SZC; Liu Y; Yao K; Softic S; Kirchner R; Bernstein A; Singhi AD; Jay DG; Kahn CR; Camargo FD; Yimlamai D Hepatology; 2020 May; 71(5):1813-1830. PubMed ID: 31505040 [TBL] [Abstract][Full Text] [Related]
23. Verteporfin Inhibits the Progression of Spontaneous Osteosarcoma Caused by Trp53 and Rb1 Deficiency in Ctsk-Expressing Cells via Impeding Hippo Pathway. Li Y; Yang S; Yang S Cells; 2022 Apr; 11(8):. PubMed ID: 35456040 [TBL] [Abstract][Full Text] [Related]
24. Piezo1 mediates endothelial atherogenic inflammatory responses via regulation of YAP/TAZ activation. Yang Y; Wang D; Zhang C; Yang W; Li C; Gao Z; Pei K; Li Y Hum Cell; 2022 Jan; 35(1):51-62. PubMed ID: 34606042 [TBL] [Abstract][Full Text] [Related]
25. The PDZ-binding motif of Yes-associated protein is required for its co-activation of TEAD-mediated CTGF transcription and oncogenic cell transforming activity. Shimomura T; Miyamura N; Hata S; Miura R; Hirayama J; Nishina H Biochem Biophys Res Commun; 2014 Jan; 443(3):917-23. PubMed ID: 24380865 [TBL] [Abstract][Full Text] [Related]
26. Atheroprotective effects of methotrexate via the inhibition of YAP/TAZ under disturbed flow. Liu D; Lv H; Liu Q; Sun Y; Hou S; Zhang L; Yang M; Han B; Wang G; Wang X; Du W; Nie H; Zhang R; Huang X; Hou J; Yu B J Transl Med; 2019 Nov; 17(1):378. PubMed ID: 31730006 [TBL] [Abstract][Full Text] [Related]
27. TNF-α-Induced YAP/TAZ Activity Mediates Leukocyte-Endothelial Adhesion by Regulating VCAM1 Expression in Endothelial Cells. Choi HJ; Kim NE; Kim BM; Seo M; Heo JH Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30388809 [TBL] [Abstract][Full Text] [Related]
28. Stearoyl-CoA-desaturase 1 regulates lung cancer stemness via stabilization and nuclear localization of YAP/TAZ. Noto A; De Vitis C; Pisanu ME; Roscilli G; Ricci G; Catizone A; Sorrentino G; Chianese G; Taglialatela-Scafati O; Trisciuoglio D; Del Bufalo D; Di Martile M; Di Napoli A; Ruco L; Costantini S; Jakopin Z; Budillon A; Melino G; Del Sal G; Ciliberto G; Mancini R Oncogene; 2017 Aug; 36(32):4573-4584. PubMed ID: 28368399 [TBL] [Abstract][Full Text] [Related]
29. The signaling protein Wnt5a promotes TGFβ1-mediated macrophage polarization and kidney fibrosis by inducing the transcriptional regulators Yap/Taz. Feng Y; Liang Y; Zhu X; Wang M; Gui Y; Lu Q; Gu M; Xue X; Sun X; He W; Yang J; Johnson RL; Dai C J Biol Chem; 2018 Dec; 293(50):19290-19302. PubMed ID: 30333225 [TBL] [Abstract][Full Text] [Related]
30. Dapagliflozin delays renal fibrosis in diabetic kidney disease by inhibiting YAP/TAZ activation. Feng L; Chen Y; Li N; Yang X; Zhou L; Li H; Wang T; Xie M; Liu H Life Sci; 2023 Jun; 322():121671. PubMed ID: 37023953 [TBL] [Abstract][Full Text] [Related]
31. YAP/TAZ as mechanobiological signaling pathway in cardiovascular physiological regulation and pathogenesis. Islam R; Hong Z Mechanobiol Med; 2024 Dec; 2(4):. PubMed ID: 39281415 [TBL] [Abstract][Full Text] [Related]
32. The Role of YAP and TAZ in Angiogenesis and Vascular Mimicry. Azad T; Ghahremani M; Yang X Cells; 2019 May; 8(5):. PubMed ID: 31052445 [TBL] [Abstract][Full Text] [Related]
33. YAP/TAZ deficiency reprograms macrophage phenotype and improves infarct healing and cardiac function after myocardial infarction. Mia MM; Cibi DM; Abdul Ghani SAB; Song W; Tee N; Ghosh S; Mao J; Olson EN; Singh MK PLoS Biol; 2020 Dec; 18(12):e3000941. PubMed ID: 33264286 [TBL] [Abstract][Full Text] [Related]
35. Reciprocal regulation of YAP/TAZ by the Hippo pathway and the Small GTPase pathway. Jang JW; Kim MK; Bae SC Small GTPases; 2020 Jul; 11(4):280-288. PubMed ID: 29457552 [TBL] [Abstract][Full Text] [Related]
36. Salvianolic acid B ameliorates atherosclerosis via inhibiting YAP/TAZ/JNK signaling pathway in endothelial cells and pericytes. Yang Y; Pei K; Zhang Q; Wang D; Feng H; Du Z; Zhang C; Gao Z; Yang W; Wu J; Li Y Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Oct; 1865(10):158779. PubMed ID: 32739616 [TBL] [Abstract][Full Text] [Related]
37. Hippo pathway inhibition by blocking the YAP/TAZ-TEAD interface: a patent review. Crawford JJ; Bronner SM; Zbieg JR Expert Opin Ther Pat; 2018 Dec; 28(12):867-873. PubMed ID: 30482112 [No Abstract] [Full Text] [Related]
38. The Efficiency of Verteporfin as a Therapeutic Option in Pre-Clinical Models of Melanoma. Lui JW; Xiao S; Ogomori K; Hammarstedt JE; Little EC; Lang D J Cancer; 2019; 10(1):1-10. PubMed ID: 30662519 [TBL] [Abstract][Full Text] [Related]
39. YAP/TAZ Are Essential for TGF-β2-Mediated Conjunctival Fibrosis. Futakuchi A; Inoue T; Wei FY; Inoue-Mochita M; Fujimoto T; Tomizawa K; Tanihara H Invest Ophthalmol Vis Sci; 2018 Jun; 59(7):3069-3078. PubMed ID: 30025139 [TBL] [Abstract][Full Text] [Related]
40. Effect of Jiawei Tongqiao Huoxue decoction in basilar artery dolichoectasia mice through yes-associated protein/transcriptional co-activator with PDZ-binding motif pathway. Liu FX; Zhang DP; Ma YM; Zhang HL; Liu XZ; Zhang ZQ; Sun RQ; Zhang YK; Miao JX; Wu ZX; Liu YL; Feng YC J Ethnopharmacol; 2023 Oct; 314():116599. PubMed ID: 37149070 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]